Inactive Instrument

RushNet, Inc. Stock Other OTC

Equities

RSHN

US7820741087

Business Support Services

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2020 4.39M 6M Sales 2021 5.9M 8.06M Capitalization 4.5M 6.14M
Net income 2020 - 0 Net income 2021 - 0 EV / Sales 2020 2.75 x
Net Debt 2020 5.87M 8.02M Net Debt 2021 5.93M 8.1M EV / Sales 2021 1.77 x
P/E ratio 2020
13.3 x
P/E ratio 2021
55 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Operating Officer 43 21-08-01
More insiders
RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through Leo Partners. It provides oral fluid toxicology testing for a range of drugs. The Quantisal Collection Procedure makes taking the sample quick and easy. HeliosDX also offers a preliminary 10-panel plus adulteration detection screen, as well as confirmation testing via its comprehensive toxicology panel. Its subsidiaries include Chattahoochee Physicians Laboratory Services, LLC; doing business as HeliosDx and Grandeza Healthcare Consultants, LLC.
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW